Abstract
In previous chapters, we presented a brief overview of the history of pharmaceutical price regulation in India over a period of 4 decades and a case to motivate the need for regulating pharmaceutical prices in India in 2013. In this chapter, we examine the details of the 2013 DPCO design before we assess its success in limiting pharmaceutical prices. We begin by recalling the key differences between the 1995 and 2013 DPCO and describing the manner in which the ceiling price is estimated by the NPPA. The chapter not only anticipates the potential problems associated with the implementation of the design but also highlights how pharmaceutical firms can circumvent price controls.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Government of India. (2011a). National list of essential medicines, 2011. New Delhi: Ministry of Chemicals and Fertilizers.
Government of India. (2011b). National pharmaceutical pricing policy, 2011 (NPPP-2011). New Delhi: Ministry of Chemicals and Fertilizers.
Government of India. (2012). National pharmaceutical pricing policy, 2012. New Delhi: Ministry of Chemicals and Fertilizers.
Gulhati, C. M. (2004). Why drug price regulation. PharmaBiz [online]. Available from http://pharmabiz.com/ArticleDetails.aspx?aid=24980&sid=21
Malhotra, P. (2010). The impact of TRIPS on India: An access to medicines perspective. London: Palgrave Macmillan.
Ray, T. J. (2013). New drug price control order of India: Is it directionally right improving access to medicines? [online]. Available from http://www.tapanray.in/new-drug-price-control-order-of-india-is-it-directionally-right-improving-access-to-medicines/
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Bhaskarabhatla, A. (2018). The Proposed Design to Fix Ceiling Prices Under 2013 DPCO. In: Regulating Pharmaceutical Prices in India. India Studies in Business and Economics. Springer, Cham. https://doi.org/10.1007/978-3-319-93393-1_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-93393-1_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-93392-4
Online ISBN: 978-3-319-93393-1
eBook Packages: Economics and FinanceEconomics and Finance (R0)